Your browser is no longer supported. Please, upgrade your browser.
NNVC NanoViricides, Inc. weekly Stock Chart
NanoViricides, Inc.
Index- P/E- EPS (ttm)-2.72 Insider Own14.97% Shs Outstand6.52M Perf Week-15.11%
Market Cap65.11M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float6.21M Perf Month1.40%
Income-13.80M PEG- EPS next Q- Inst Own21.20% Short Float4.18% Perf Quarter39.42%
Sales- P/S- EPS this Y11.10% Inst Trans- Short Ratio0.28 Perf Half Y183.20%
Book/sh2.20 P/B3.30 EPS next Y- ROA-103.30% Target Price- Perf Year49.05%
Cash/sh0.68 P/C10.67 EPS next 5Y- ROE-132.00% 52W Range1.27 - 19.20 Perf YTD188.84%
Dividend- P/FCF- EPS past 5Y15.10% ROI- 52W High-63.54% Beta1.18
Dividend %- Quick Ratio2.90 Sales past 5Y- Gross Margin- 52W Low450.62% ATR0.75
Employees17 Current Ratio2.90 Sales Q/Q- Oper. Margin- RSI (14)49.43 Volatility12.21% 10.13%
OptionableNo Debt/Eq0.08 EPS Q/Q-108.50% Profit Margin- Rel Volume0.40 Prev Close7.25
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume927.12K Price7.00
Recom- SMA20-0.73% SMA50-4.52% SMA20031.63% Volume370,875 Change-3.45%
Feb-11-15Initiated Midtown Partners Strong Buy $5.30
Jun-30-20 06:15AM  
Jun-25-20 11:05AM  
Jun-23-20 06:15AM  
Jun-09-20 07:46AM  
May-26-20 06:15AM  
May-21-20 08:30AM  
May-20-20 06:15AM  
May-18-20 06:15AM  
May-13-20 10:12AM  
May-12-20 12:57PM  
May-04-20 06:15AM  
Apr-29-20 06:15AM  
Apr-21-20 02:00PM  
Apr-13-20 06:15AM  
Apr-07-20 02:31PM  
Apr-06-20 06:15AM  
Mar-31-20 07:30AM  
Mar-16-20 06:15AM  
Mar-14-20 10:18AM  
Mar-13-20 05:42PM  
Mar-09-20 02:44PM  
Mar-05-20 04:11PM  
Feb-28-20 04:57PM  
Feb-25-20 03:25PM  
Feb-24-20 08:39AM  
Feb-18-20 01:01PM  
Feb-12-20 06:15AM  
Feb-10-20 07:30AM  
Feb-06-20 05:50PM  
Feb-04-20 07:30AM  
Feb-03-20 02:17PM  
Feb-01-20 10:53AM  
Jan-31-20 09:09AM  
Jan-30-20 06:20PM  
Jan-28-20 02:23PM  
Jan-27-20 04:29PM  
Jan-24-20 10:45PM  
Jan-23-20 03:14PM  
Jan-22-20 09:09AM  
Jan-21-20 08:35PM  
Jan-09-20 08:00AM  
Jan-07-20 08:30AM  
Jan-06-20 07:30AM  
Dec-17-19 08:30AM  
Dec-09-19 08:30AM  
Dec-06-19 08:30AM  
Dec-03-19 07:30AM  
Dec-02-19 07:30AM  
Nov-19-19 09:00AM  
Nov-04-19 07:30AM  
Oct-31-19 07:30AM  
Oct-25-19 09:20AM  
Oct-09-19 07:30AM  
Oct-03-19 07:30AM  
Sep-30-19 07:30AM  
Sep-20-19 11:33AM  
Sep-12-19 09:00AM  
Aug-26-19 07:30AM  
Aug-05-19 07:00AM  
Jul-11-19 10:10AM  
Jun-10-19 07:00AM  
Jun-03-19 07:00AM  
May-20-19 07:00AM  
Apr-24-19 01:00PM  
Apr-16-19 07:00AM  
Apr-09-19 09:00AM  
Mar-26-19 07:00AM  
Mar-12-19 07:00AM  
Mar-05-19 07:00AM  
Feb-27-19 09:48AM  
Feb-26-19 07:00AM  
Feb-19-19 07:28AM  
Feb-11-19 07:00AM  
Feb-04-19 07:00AM  
Jan-15-19 11:50AM  
Jan-02-19 07:00AM  
Nov-26-18 07:35AM  
Nov-13-18 10:35AM  
NanoViricides, Inc., a nano-biopharmaceutical company, discovers, develops, and commercializes drugs for the treatment of viral infections. Its products pipeline includes HerpeCide Dermal Topical and Eye Drops for the treatment of shingles, PHN, chickenpox, herpes, recurrent herpes labialis, genital herpes, and ocular herpes keratitis; and HerpeCide IntraOcular Injection for viral acute retinal necrosis. The company also develops FluCide Broad-Spectrum Anti-Influenza nanoviricide, which is injectable for hospitalized patients and oral for outpatients; Nanoviricide eye drops for viral diseases of the external eye; DengueCide for treatment of all types of Dengue viruses; and HIVCide that is an escape-resistant anti-HIV nanoviricide. In addition, it is also involved in research and development of other nanoviricides drug projects for treatment of different viruses and indications; and HerpeCide program expansion drug projects for different herpes viruses for different indications. NanoViricides, Inc. was founded in 2005 and is based in Shelton, Connecticut.